 SARASOTA, Fla., July 14, 2021 PRNewswire -- INVO Bioscience, Inc. NASDAQ: INVO, a medical device company focused on commercializing the worlds only in vivo Culture System IVC, INVOcell, an effective and affordable treatment for patients diagnosed with infertility, today announced the appointment of Barbara Levy, M.D. 